Bunge Limited (BG) Misses Q2 EPS by 1c, Beats on Revenues
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/2/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- DataMeds AI's Corexa Pharmacy tops $1M in monthly revenue
- Equities rebound to close higher as surging Treasury yields recede
- onsemi cuts Synaptics deal price to $5.7B after rival bid
- Wells Fargo names 13 stocks as overweight tactical ideas
- Twilio, Vylor set to join S&P 500 as index reshuffles members
Bunge Limited (BG) Granted Approval by U.S. FDA To Claim Soybean Oil as Heart Healthy
July 31, 2017 12:26 PM EDTBunge North America, the North American arm of Bunge Limited (NYSE: BG), is pleased to announce that the U.S. Food and Drug Administration (FDA) approved its petition for a qualified health claim linking consumption of soybean oil to reduced risk of coronary heart disease. Bunge independently filed a petition with the FDA that included a summary of human clinical studies from top nutrition researchers demonstrating the heart health potential of soybean oilAmerica's most commonly used ingredient and top dietary source of omega-3 fats. Upon review, the FDA will allow companies to communicate... More
